Evolving Treatments and Management Considerations for Patients with Hemophilia A
Released On
February 28, 2023
Expires On
February 28, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Hematology
Topic(s)
Bleeding Disorders, Hemophilia
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Sanofi.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is directed toward hematologists and specialty nurse practitioners and physician assistants involved in the management of patients with hemophilia A.
Activity Overview
This online activity is designed to provide a concise and focused overview on an important clinical topic and includes information on current and emerging therapies for patients with hemophilia A. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate clinical trial data for current and emerging therapies for patients with hemophilia A
- Design an individualized care plan to manage complications in patients with hemophilia A
Faculty
Kenneth A. Bauer, MD
Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, MA
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Kenneth A. Bauer, MD, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.